SCPH Insider Trading - scPharmaceuticals Inc.

Deler fremragende	53,761,939 shares
Insideraktier	13.362.926 shares
Insider ejerskab	24,86 %
Total Insiders	37

Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

5592 out of 11308

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000 %( )

5672 out of 11219

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

scPharmaceuticals Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider	Aktier Ejet	Dele Justeret
5AM Co-Investors IV, L.P. 10% Owner - [10%]	130.135	410.268
5AM Opportunities I (GP), LLC 10% Owner - [10%]	1.156.068	410.268
5AM Opportunities I, L.P. -	1.156.068	410.268
5AM Partners IV, LLC 10% Owner - [10%]	410.268	410.268
5AM Ventures IV, L.P. 10% Owner - [10%]	130.135	410.268
Mette Kirstine Agger Director, 10% Owner - [D] [10%]	3.183.986	3.183.986
Minnie Baylor-Henry	6.124
Sara Bonstein	12.248
Abraham Ceesay	80.971
Dorothy Coleman Director - [D]	14.348	14.348
John D Diekman 10% Owner - [10%]	130.135	410.268
Mason Freeman	6.124

Insider	Aktier Ejet	Dele Justeret
Abhay Gandhi	0
Hudson Frederick M.	6.124
Samuel D Isaly 10% Owner - [10%]	3.409.865	3.409.865
Ignelzi Troy A.	42.616
Khattar Jack A. Director - [D]	5.000	5.000
Peter Kolchinsky 10% Owner - [10%]	2.727.446	2.727.446
Lundbeckfond Invest A/S 10% Owner - [10%]	3.183.986	3.183.986
Rachael Nokes CFO and Treasurer - [O]	156.061	156.061
Orbimed Advisors Llc 10% Owner - [10%]	252.858	252.858
OrbiMed Capital GP VI LLC 10% Owner - [10%]	231.200	252.858
OrbiMed Genesis GP LLC 10% Owner - [10%]	231.200	252.858
Kush Parmar	6.124

Insider	Aktier Ejet	Dele Justeret
Ra Capital Management, Llc 10% Owner - [10%]	2.727.446	2.727.446
RA Capital Healthcare Fund LP 10% Owner - [10%]	2.727.446	2.727.446
Scott M Rocklage 10% Owner - [10%]	130.135	410.268
Leonard D Schaeffer Director - [D]	54.451	54.451
Dilip S Shanghvi 10% Owner - [10%]	357.143	357.143
Jonathan Silverstein Director - [D]	2.576.532	2.576.532
Pharmaceutical Industries Ltd Sun 10% Owner - [10%]	357.143	357.143
Schwab Andrew J. 10% Owner - [10%]	537.301	410.268
Shah Rajeev M. 10% Owner - [10%]	2.727.446	2.727.446
Sun Pharma (Netherlands) B.V. 10% Owner - [10%]	357.143	357.143
Sun Pharmaceutical Industries, Inc. 10% Owner - [10%]	357.143	357.143
John H Tucker President and CEO, Director - [D] [O]	440.847	440.847
Klaus R Dr Veitinger	6.124

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SCPH / scPharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks	Pris kl Maks	Maks Fortjeneste ($)	Maks. afkast (%)
2024-08-13	ORBIMED ADVISORS LLC	478.342	4,0000	478.342	4,0000	1.913.368	345	5.8400	880.149	46,00
2024-08-13	ORBIMED ADVISORS LLC	21.658	4,0000	21.658	4,0000	86.632
2022-11-25	ORBIMED ADVISORS LLC	762.380	5,2500	762.380	5,2500	4.002.495
2021-12-03	Khattar Jack A.	5.000	3,9138	5.000	3,9138	19.569
2021-12-03	Tucker John H	10.000	3,9553	10.000	3,9553	39.553
2020-05-26	Schwab Andrew J.	578.034	8,6500	578.034	8,6500	4.999.994
2020-05-21	ORBIMED ADVISORS LLC	231.200	8,6500	231.200	8,6500	1.999.880
2020-05-21	ORBIMED ADVISORS LLC	1.156.083	8,6500	1.156.083	8,6500	10.000.118
2020-02-14	RA CAPITAL MANAGEMENT, LLC	271.993	8,2000	271.993	8,2000	2.230.343

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SCPH / scPharmaceuticals Inc. Insider Trades

Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SCPH / scPharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min	Pris kl Min	Max tab Undgået ($)	Max tab Undgået (%)
2022-10-10	5AM Partners IV, LLC	87.036	4,0900	87.036	4,0900	355.977	0	4.0200	-6.092	-1,71
2022-10-10	5AM Partners IV, LLC	19.017	4,0900	19.017	4,0900	77.780
2022-10-10	5AM Partners IV, LLC	456.413	4,0900	456.413	4,0900	1.866.729
2022-10-06	5AM Partners IV, LLC	5.808	5,0200	5.808	5,0200	29.156
2022-10-06	5AM Partners IV, LLC	1.269	5,0200	1.269	5,0200	6.370
2022-10-06	5AM Partners IV, LLC	30.457	5,0200	30.457	5,0200	152.894
2022-09-07	5AM Partners IV, LLC	6.793	4,7500	6.793	4,7500	32.267
2022-09-07	5AM Partners IV, LLC	30.173	4,7500	30.173	4,7500	143.322
2022-09-07	5AM Partners IV, LLC	163.034	4,7500	163.034	4,7500	774.412

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil Dato	Handle Dato	Form	Insider	Ticker	Sikkerhedstitel	Kode	Direkte	Dyrke motion Pris	Enhed Pris	Enheder Ændret	Værdi Ændret (1K)	Tilbage Muligheder	Tilbage Aktier
2025-02-12	2025-02-11	4	Tucker John H	SCPH	Common Stock	A - Award	D			-200.000			440.847
2025-02-12	2025-02-11	4	Nokes Rachael	SCPH	Common Stock	A - Award	D			88.445			156.061
2025-01-07	2025-01-03	4	Nokes Rachael	SCPH	Common Stock	F - Taxes	D		3,5587	-5.235	-19		67.616
2025-01-07	2025-01-03	4	Tucker John H	SCPH	Common Stock	F - Taxes	D		3,5587	-13.360	-48		240.847
2024-08-28	2024-08-06	4/A	Nokes Rachael	SCPH	Common Stock	M - Exercise	D		1,6600	10.445	17		72.851
2024-08-28	2024-08-26	4	SCHAEFFER LEONARD D	SCPH	Common Stock	M - Exercise	D		3,3700	6.124	21		54.451
2024-08-28	2024-08-26	4	SCHAEFFER LEONARD D	SCPH	Common Stock	M - Exercise	D		1,6600	5.223	9		48.327
2024-08-15	2024-08-13	4	ORBIMED ADVISORS LLC See footnotes	SCPH	Common Stock	P - Purchase	I		4,0000	21.658	87		252.858
2024-08-15	2024-08-13	4	ORBIMED ADVISORS LLC See footnotes	SCPH	Common Stock	P - Purchase	I		4,0000	478.342	1.913		5.806.670
2024-08-08	2024-08-06	4	Nokes Rachael	SCPH	Common Stock	M - Exercise	D			10.445			72.851
2024-01-22	2024-01-18	4	Nokes Rachael	SCPH	Common Stock	A - Award	D			41.840			62.406
2024-01-22	2024-01-18	4	Tucker John H	SCPH	Common Stock	A - Award	D			113.560			254.207
2024-01-03	2024-01-02	4	Nokes Rachael	SCPH	Common Stock	F - Taxes	D		6,3900	-1.027	-7		20.566
2024-01-03	2024-01-02	4	Tucker John H	SCPH	Common Stock	F - Taxes	D		6,3900	-4.942	-32		140.647
2023-01-23	2023-01-19	4	Nokes Rachael	SCPH	Common Stock	A - Award	D		6,1400	11.700	72		21.593
2023-01-23	2021-02-25	4	Nokes Rachael	SCPH	Common Stock	F - Taxes	D		7,2700	-1.976	-14		9.893
2023-01-23	2020-02-25	4	Nokes Rachael	SCPH	Common Stock	F - Taxes	D		10,0900	-1.981	-20		11.869
2023-01-23	2023-01-19	4	Tucker John H	SCPH	Common Stock	A - Award	D		6,1400	66.665	409		145.589
2022-11-29	2022-11-25	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	P - Purchase	I		5,2500	762.380	4.002		5.328.328
2022-10-11	2022-10-10	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		4,0900	-87.036	-356		410.268
2022-10-11	2022-10-10	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		4,0900	-19.017	-78		92.983
2022-10-11	2022-10-10	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		4,0900	-456.413	-1.867		2.231.601
2022-10-11	2022-10-06	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		5,0200	-5.808	-29		497.304
2022-10-11	2022-10-06	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		5,0200	-1.269	-6		112.000
2022-10-11	2022-10-06	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		5,0200	-30.457	-153		2.688.014
2022-10-11	2022-10-07	4	Tucker John H	SCPH	Common Stock	F - Taxes	D		4,9800	-10.288	-51		78.924
2022-10-11	2022-10-07	4	Tucker John H	SCPH	Common Stock	M - Exercise	D			42.250			89.212
2022-09-08	2022-09-07	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		4,7500	-30.173	-143		503.112
2022-09-08	2022-09-07	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		4,7500	-6.793	-32		113.269
2022-09-08	2022-09-07	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		4,7500	-163.034	-774		2.718.471
2022-09-08	2022-09-06	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		5,5200	-4.016	-22		533.285
2022-09-08	2022-09-06	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		5,5200	-904	-5		120.062
2022-09-08	2022-09-06	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		5,5200	-21.702	-120		2.881.505
2022-04-13	2022-04-11	4	5AM Partners IV, LLC By 5AM Opportunities I, L.P.	SCPH	Common Stock	S - Sale	I		5,0000	-40.733	-204		537.301
2022-04-13	2022-04-11	4	5AM Partners IV, LLC By 5AM Co-Investors IV, L.P.	SCPH	Common Stock	S - Sale	I		5,0000	-9.171	-46		120.966
2022-04-13	2022-04-11	4	5AM Partners IV, LLC By 5AM Ventures IV, L.P.	SCPH	Common Stock	S - Sale	I		5,0000	-220.096	-1.100		2.903.207
2022-02-01	2022-01-31	4	Nokes Rachael	SCPH	Stock Option (Right to Buy)	A - Award	D	4,31		54.700		54.700
2022-02-01	2022-01-31	4	Tucker John H	SCPH	Stock Option (Right to Buy)	A - Award	D	4,31		249.000		249.000
2021-12-06	2021-12-03	4	Khattar Jack A.	SCPH	Common Stock	P - Purchase	D		3,9138	5.000	20		5.000
2021-12-06	2021-12-03	4	Tucker John H	SCPH	Common Stock	P - Purchase	D		3,9553	10.000	40		46.962
2021-06-10	2021-06-08	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	A - Award	D	5,70		16.300		16.300
2021-06-10	2021-06-08	4	Baylor-Henry Minnie	SCPH	Stock Option (Right to Buy)	A - Award	D	5,70		16.300		16.300
2021-06-10	2021-06-08	4	Khattar Jack A.	SCPH	Stock Option (Right to Buy)	A - Award	D	5,70		16.300		16.300
2021-06-10	2021-06-08	4	Abraham William Tober	SCPH	Stock Option (Right to Buy)	A - Award	D	5,70		16.300		16.300
2021-06-10	2021-06-08	4	Hudson Frederick M.	SCPH	Stock Option (Right to Buy)	A - Award	D	5,70		16.300		16.300
2021-06-10	2021-06-08	4	Bonstein Sara	SCPH	Stock Option (Right to Buy)	A - Award	D	5,70		16.300		16.300
2021-06-10	2021-06-08	4	VEITINGER KLAUS R DR	SCPH	Stock Option (Right to Buy)	A - Award	D	5,70		16.300		16.300
2021-03-16	2021-03-15	4	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	S - Sale	I		7,0332	-110.588	-778		2.727.446
2021-03-16	2021-03-12	4	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	S - Sale	I		7,2162	-39.469	-285		2.838.034
2021-02-17	2021-02-16	4	Abraham William Tober	SCPH	Stock Option (right to buy)	A - Award	D	7,25		32.600		32.600
2021-01-27	2021-01-25	4	Tucker John H	SCPH	Stock Option (Right to Buy)	A - Award	D	7,06		112.050		112.050
2021-01-27	2021-01-25	4	Nokes Rachael	SCPH	Stock Option (Right to Buy)	A - Award	D	7,06		49.200		49.200
2020-07-13	2020-07-08	4	Bonstein Sara	SCPH	Stock Option (right to buy)	A - Award	D	8,23		12.248		12.248
2020-07-02	2020-06-30	4	Tucker John H	SCPH	Stock Option (right to buy)	A - Award	D	3,25		42.250		42.250
2020-07-02	2020-06-30	4	Tucker John H	SCPH	Restricted Stock Units	M - Exercise	D			-42.250		0
2020-07-02	2020-06-30	4	Tucker John H	SCPH	Common Stock	F - Taxes	D		7,3600	-10.288	-76		36.962
2020-07-02	2020-06-30	4	Tucker John H	SCPH	Common Stock	M - Exercise	D			42.250			47.250
2020-06-11	2020-06-09	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	A - Award	D	7,96		6.124		6.124
2020-06-11	2020-06-09	4	Freeman Mason	SCPH	Stock Option (Right to Buy)	A - Award	D	7,96		6.124		6.124
2020-06-11	2020-06-09	4	Khattar Jack A.	SCPH	Stock Option (Right to Buy)	A - Award	D	7,96		6.124		6.124
2020-06-11	2020-06-09	4	Baylor-Henry Minnie	SCPH	Stock Option (Right to Buy)	A - Award	D	7,96		6.124		6.124
2020-06-11	2020-06-09	4	VEITINGER KLAUS R DR	SCPH	Stock Option (Right to Buy)	A - Award	D	7,96		6.124		6.124
2020-06-11	2020-06-09	4	Hudson Frederick M.	SCPH	Stock Option (Right to Buy)	A - Award	D	7,96		6.124		6.124
2020-06-11	2020-06-09	4	Agger Mette Kirstine	SCPH	Stock Option (Right to Buy)	A - Award	D	7,96		6.124		6.124
2020-06-11	2020-06-09	4	Coleman Dorothy	SCPH	Stock Option (Right to Buy)	A - Award	D	7,96		6.124		6.124
2020-05-28		3	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	SCPH	Common Stock		I						1.156.068
2020-05-28		3	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	SCPH	Common Stock		I						1.156.068
2020-05-28		3	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	SCPH	Common Stock		I						1.156.068
2020-05-28		3	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	SCPH	Common Stock		I						1.156.068
2020-05-28	2020-05-26	4	Schwab Andrew J. By 5AM Opportunities I, L.P.	SCPH	Common Stock	P - Purchase	I		8,6500	578.034	5.000		578.034
2020-05-26	2020-05-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	P - Purchase	I		8,6500	231.200	2.000		231.200
2020-05-26	2020-05-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	P - Purchase	I		8,6500	1.156.083	10.000		4.565.948
2020-02-21	2020-02-14	4/A	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	P - Purchase	I		8,2000	271.993	2.230		3.518.998
2020-02-19	2020-02-14	4	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	P - Purchase	I		8,2000	271.993	2.230		3.247.005
2020-01-14	2020-01-10	4	Nokes Rachael	SCPH	Stock Option (Right to Buy)	A - Award	D	5,81		44.500		44.500
2020-01-14	2020-01-10	4	Tucker John H	SCPH	Stock Option (Right to Buy)	A - Award	D	5,81		127.500		127.500
2019-12-17	2019-12-13	4	Tucker John H	SCPH	Common Stock	P - Purchase	D		5,2377	5.000	26		5.000
2019-06-20	2019-06-18	4	Hudson Frederick M.	SCPH	Stock Option (Right to Buy)	A - Award	D	3,37		6.124		6.124
2019-06-20	2019-06-18	4	Coleman Dorothy	SCPH	Stock Option (Right to Buy)	A - Award	D	3,37		6.124		6.124
2019-06-20	2019-06-18	4	VEITINGER KLAUS R DR	SCPH	Stock Option (Right to Buy)	A - Award	D	3,37		6.124		6.124
2019-06-20	2019-06-18	4	Khattar Jack A.	SCPH	Stock Option (Right to Buy)	A - Award	D	3,37		6.124		6.124
2019-06-20	2019-06-18	4	Freeman Mason	SCPH	Stock Option (Right to Buy)	A - Award	D	3,37		6.124		6.124
2019-06-20	2019-06-18	4	Agger Mette Kirstine	SCPH	Stock Option (Right to Buy)	A - Award	D	3,37		6.124		6.124
2019-06-20	2019-06-18	4	Baylor-Henry Minnie	SCPH	Stock Option (Right to Buy)	A - Award	D	3,37		6.124		6.124
2019-06-20	2019-06-18	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	A - Award	D	3,37		6.124		6.124
2019-04-15	2019-04-11	4	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock	P - Purchase	I		2,7000	389.862	1.053		3.247.005
2019-03-06		3	Nokes Rachael	SCPH	Common Stock		D						27.700
2019-03-06		3	Nokes Rachael	SCPH	Common Stock		D						27.700
2019-03-06		3	Nokes Rachael	SCPH	Common Stock		D						27.700
2018-07-24	2018-07-20	4	Freeman Mason	SCPH	Stock Option (Right to Buy)	A - Award	D	4,80		12.248		12.248
2018-07-24	2018-07-20	4	Baylor-Henry Minnie	SCPH	Stock Option (Right to Buy)	A - Award	D	4,80		12.248		12.248
2018-06-21	2018-06-19	4	Coleman Dorothy	SCPH	Stock Option (Right to Buy)	A - Award	D	5,53		6.124		6.124
2018-06-21	2018-06-19	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	A - Award	D	5,53		6.124		6.124
2018-06-21	2018-06-19	4	Khattar Jack A.	SCPH	Stock Option (Right to Buy)	A - Award	D	5,53		6.124		6.124
2018-06-21	2018-06-19	4	PARMAR KUSH	SCPH	Stock Option (Right to Buy)	A - Award	D	5,53		6.124		6.124
2018-06-21	2018-06-19	4	VEITINGER KLAUS R DR	SCPH	Stock Option (Right to Buy)	A - Award	D	5,53		6.124		6.124
2018-06-21	2018-06-19	4	Agger Mette Kirstine	SCPH	Stock Option (Right to Buy)	A - Award	D	5,53		6.124		6.124
2018-06-21	2018-06-19	4	Hudson Frederick M.	SCPH	Stock Option (Right to Buy)	A - Award	D	5,53		12.248		12.248
2018-02-13	2017-11-21	4/A	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Common Stock	P - Purchase	I		14,0000	654.762	9.167		3.183.986
2018-01-19	2018-01-17	4	Ceesay Abraham	SCPH	Stock Option (Right to Buy)	A - Award	D	12,23		80.971		80.971
2018-01-19	2018-01-17	4	Tucker John H	SCPH	Stock Option (Right to Buy)	A - Award	D	12,23		100.000		100.000
2018-01-19	2018-01-17	4	Ignelzi Troy A.	SCPH	Stock Option (Right to Buy)	A - Award	D	12,23		42.616		42.616
2017-12-20	2017-12-19	4	SCHAEFFER LEONARD D	SCPH	Stock Option (Right to Buy)	M - Exercise	D	1,66		-22.631		5.223
2017-12-20	2017-12-19	4	SCHAEFFER LEONARD D	SCPH	Common Stock	M - Exercise	D		1,6600	22.631	38		57.449
2017-11-24	2017-11-21	4	SUN PHARMACEUTICAL INDUSTRIES LTD By Sun Pharmaceutical Industries, Inc.	SCPH	Series B Preferred Stock	C - Conversion	I			-13.000.000		0
2017-11-24	2017-11-21	4	SUN PHARMACEUTICAL INDUSTRIES LTD By Sun Pharma (Netherlands) B.V.	SCPH	Common Stock	P - Purchase	I		14,0000	357.143	5.000		357.143
2017-11-24	2017-11-21	4	SUN PHARMACEUTICAL INDUSTRIES LTD By Sun Pharmaceutical Industries, Inc.	SCPH	Common Stock	C - Conversion	I			1.810.536			1.810.536
2017-11-21		3	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock		I						5.714.286
2017-11-21		3	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock		I						5.714.286
2017-11-21		3	RA CAPITAL MANAGEMENT, LLC	SCPH	Common Stock		I						5.714.286
2017-11-21	2017-11-21	4	SCHAEFFER LEONARD D By: Schaeffer Holdings LLC	SCPH	Series A Preferred Stock	C - Conversion	I			-309.501		0
2017-11-21	2017-11-21	4	SCHAEFFER LEONARD D	SCPH	Series A Preferred Stock	C - Conversion	D			-250.000		0
2017-11-21	2017-11-21	4	SCHAEFFER LEONARD D By: Schaeffer Holdings LLC	SCPH	Common Stock	C - Conversion	I			43.104			43.104
2017-11-21	2017-11-21	4	SCHAEFFER LEONARD D	SCPH	Common Stock	C - Conversion	D			34.818			34.818
2017-11-21	2017-11-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Series B Preferred Stock	C - Conversion	I			-18.500.000		0
2017-11-21	2017-11-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	P - Purchase	I		14,0000	833.333	11.667		3.409.865
2017-11-21	2017-11-21	4	ORBIMED ADVISORS LLC See Footnotes	SCPH	Common Stock	C - Conversion	I			2.576.532			2.576.532
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Series B Preferred Stock	C - Conversion	I			-302.652		0
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Series A Preferred Stock	C - Conversion	I			-443.708		0
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Series B Preferred Stock	C - Conversion	I			-7.263.649		0
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Series A Preferred Stock	C - Conversion	I			-10.649.003		0
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Common Stock	P - Purchase	I		14,0000	26.190	367		130.135
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Common Stock	C - Conversion	I			42.150			103.945
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Co-Investors IV, L.P.	SCPH	Common Stock	C - Conversion	I			61.795			61.795
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Common Stock	P - Purchase	I		14,0000	628.572	8.800		3.123.302
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Common Stock	C - Conversion	I			1.011.623			2.494.730
2017-11-21	2017-11-21	4	5AM Partners IV, LLC by 5AM Ventures IV, L.P.	SCPH	Common Stock	C - Conversion	I			1.483.107			1.483.107
2017-11-21	2017-11-21	4	SILVERSTEIN JONATHAN By: OrbiMed Private Investments VI, L.P.	SCPH	Series B Preferred Stock	C - Conversion	I			-18.500.000		0
2017-11-21	2017-11-21	4	SILVERSTEIN JONATHAN By: OrbiMed Private Investments VI, L.P.	SCPH	Common Stock	C - Conversion	I			2.576.532			2.576.532
2017-11-21	2017-11-21	4	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Series B Preferred Stock	C - Conversion	I			-7.067.945		0
2017-11-21	2017-11-21	4	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Series A Preferred Stock	C - Conversion	I			-11.092.383		0
2017-11-21	2017-11-21	4	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Common Stock	C - Conversion	I			984.366			2.529.224
2017-11-21	2017-11-21	4	Agger Mette Kirstine By: Lundbeckfond Invest A/S	SCPH	Common Stock	C - Conversion	I			1.544.858			1.544.858
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Series B Preferred Stock	C - Conversion	D			-7.067.945		0
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Series A Preferred Stock	C - Conversion	D			-11.092.383		0
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Common Stock	P - Purchase	D		14,0000	654.762	9.167		3.183.986
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Common Stock	C - Conversion	D			984.366			2.529.224
2017-11-21	2017-11-21	4	Lundbeckfond Invest A/S	SCPH	Common Stock	C - Conversion	D			1.544.858			1.544.858
2017-11-21	2017-11-21	4	Coleman Dorothy	SCPH	Series A Preferred Stock	C - Conversion	D			-103.024		0
2017-11-21	2017-11-21	4	Coleman Dorothy	SCPH	Common Stock	C - Conversion	D			14.348			14.348

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

Konvertering af derivat

Salg eller overførsel af værdipapirer tilbage til virksomheden

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

Gave af værdipapirer af eller til insideren

Aktieswaps og lignende sikringstransaktioner

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

En transaktion rapporteret frivilligt på formular 4

Andet (ledsaget af en fodnote, der beskriver transaktionen)

SCPH / scPharmaceuticals Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5